ISPOR 18th ANNUAL INTERNATIONAL MEETING AWARDS WINNERS
 

The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, Asia-Pacific and Latin America Conferences.

This year, the ISPOR judges evaluated podium presentations and nominated poster presentations. All podium presentations are considered for an award. Poster presentations in the top 20%, based on abstract review score, are considered and eligible for a poster presentation award.
Evaluations of scientific merit were based upon the following criteria:

  • Background provides appropriate perspective / context for the subject
  • Objectives / research questions are clearly stated
  • Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
  • Data sources and/or sampling procedures are clear and appropriate
  • Data analyses are appropriate
  • Research objectives are met/addressed
  • Implications of findings are discussed
  • Factual information is kept separate from interpretations or implications
  • Abstract is presented in an unbiased manner
  • Clarity of presentation

THE RECIPIENTS  ARE: . . .

ISPOR Best Podium Research Presentation Awards

Best General Podium Presentations

CA1 - BREAST CANCER PATIENTS RECEIVING GUIDELINE-CONCORDANT ADJUVANT THERAPY REGIMENS HAVE BETTER ALL-CAUSE AND DISEASE-SPECIFIC SURVIVAL: NEW FINDINGS FROM RURAL GEORGIA
Lipscomb J1, Guy GP2, Gillespie T3, Goodman M1, Richardson LC2, Ward KC1
1Emory University, Rollins School of Public Health, Atlanta, GA, USA, 2Centers for Disease Control and Prevention, Atlanta, GA, USA, 3Emory University School of Medicine, Atlanta, GA, USA

CA3 - TREATMENT PATTERNS AFTER CASTRATION RESISTANT PROSTATE CANCER (CRPC) DIAGNOSIS: A EUROPEAN PHYSICIAN SURVEY
Pokras SM1, Zyczynski TM2, Lees M3, Jiao X1, Blanchette C1, Powers J4
1IMS Health, Alexandria, VA, USA, 2Bristol-Myers Squibb, Princeton, NJ, USA, 3Bristol-Myers Squibb, Rueil-Malmaison, France, 4University of Colorado, Denver, Aurora, CO, USA

SB2 - MEDICAL, DRUG, AND WORK-LOSS COSTS OF DIABETIC FOOT ULCERS
Rice JB1, Desai U1, Cummings AK1, Birnbaum HG1, Skornicki M2, Parsons N2
1Analysis Group, Inc., Boston, MA, USA, 2Organogenesis Inc., Canton, MA, USA


Best Student Podium Research Presentations

DU4 - THE ASSOCIATION OF BURN INJURIES AND PSEUDOEPHEDRINE SALES
Goodin AJ, Perin NR, Freeman PR, Talbert J, Wittmer D, Blumenschein K
University of Kentucky, Lexington, KY, USA

MD2 - SKELETAL-RELATED EVENTS AND MORTALITY AMONG SEER-MEDICARE PATIENTS WITH METASTATIC PROSTATE CANCER: THE IMPLICATIONS OF MEASUREMENT APPROACH
Onukwugha E1, Yong C1, Mullins CD1, Seal B2, Hussain A3
1University of Maryland School of Pharmacy, Baltimore, MD, USA, 2Bayer HealthCare Pharmaceuticals, Inc., Pine Brook, NJ, USA, 3University of Maryland School of Medicine, Baltimore, MD, USA

MD3 - ASSOCIATION BETWEEN INHALED ANTICHOLINERGICS USE AND ALL-CAUSE MORTALITY AMONG ELDERLY MEDICARE BENEFICIARIES WITH RESPIRATORY DISEASES
Ajmera MR1, Pan X1, Findley P2, Rust G3, Sambamoorthi U4
1West Virginia University, Morgantown, WV, USA, 2Rutgers University, New Brunswick, NJ, USA, 3Morehouse School of Medicine, Atlanta, GA, USA, 4West Virginia University School of Pharmacy, Morgantown, WV, USA

Best New Investigator Podium Research Presentations

HT1 - INTER-COUNTRY VARIABILITY IN COVERAGE DECISIONS FOR ORPHAN DRUGS: CRITERIA DRIVING HTA RECOMMENDATIONS IN SIX COUNTRIES
Nicod E, Kanavos P
London School of Economics and Political Science, London, UK

RM2 - USE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS AND RISK OF DEMENTIA IN HEART FAILURE
Chitnis AS1, Johnson ML2, Aparasu RR2, Chen H2, Kunik ME3, Schulz PE4
1United BioSource Corporation, Lexington, MA, USA, 2University of Houston, Houston, TX, USA, 3Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC), Houston, TX, USA, 4The University of Texas Health Science Center at Houston, Houston, TX, USA

RM3 - SULFONYLUREAS ARE ASSOCIATED WITH ELEVATED RISK OF HIP FRACTURES AMONG ELDERLY MEN AND WOMEN WITH TYPE-2 DIABETES
Rajpathak SN1, Fu C1, Engel SS1, Brodovicz KG1, Lapane K2
1Merck & Co, North Wales, PA, USA, 2University of Massachussets, Worcester, MA, USA


ISPOR Best Poster Research Presentation Awards

Best General Poster Research Presentations

PRM188 - EFFICIENCY OF U.S. DIALYSIS CENTERS: AN UPDATED EXAMINATION OF FACILITY CHARACTERISTICS THAT INFLUENCE PRODUCTION OF DIALYSIS TREATMENTS
Shreay S1;Stephens M2;Ma M3;Mccluskey J3;Mittelhammer R3, Gitlin MD1
1Amgen, Thousand Oaks, CA, USA, 2Prima Health Analytics, Weymouth, MA, USA, 3Washington State University, Pullman, WA, USA

PRM51 - THERE BUT FOR GRACE? A VALIDATED SCREENING TOOL FOR QUALITY OBSERVATIONAL STUDIES OF COMPARATIVE EFFECTIVENESS
Dreyer NA1;Velentgas P1;Westrich KD2, Dubois RW2
1Quintiles Outcome, Cambridge, MA, USA, 2National Pharmaceutical Council, Washington, DC, USA

PIN83 - ANTIRETROVIRAL ADHERENCE AMONG MEDICAID-INSURED HIV PATIENTS INITIATING CURRENT GUIDELINE-PREFERRED ANTIRETROVIRAL THERAPY REGIMENS
Juday T1;Farr A2;Johnston SS2;Chu BC3, Hebden T4
1Bristol-Myers Squibb Company, Plainsboro, NJ, USA, 2Truven Health Analytics, Washington, DC, USA, 3Truven Health Analytics, Santa Barbara, CA, USA, 4Bristol-Myers Squibb, Plainsboro, NJ, USA


Best Student Poster Research Presentations

PRM31 - COMPARISON OF INFORMAL CARE TIME AND COSTS IN DIFFERENT AGE-RELATED DEMENTIAS: A REVIEW
Costa N1;Ferlicoq L2;Derumeaux-Burel H2;Rapp T3;Garnault V2;Gillette S2;Andrieu S1;Vellas B4;Lamure M5;Grand A2, Molinier L6
1INSERM, Toulouse, France, 2University hospital of Toulouse, Toulouse, France, 3University of Paris Descartes, Paris, France, 4University of Toulouse III, Toulouse, France, 5University of Lyon, Bron, France, 6University Hospital of Toulouse, Toulouse, France

PSY51 - COST TO SOCIETY DUE TO UNDEREMPLOYMENT IN PERSONS WITH HEMOPHILIA A AND B – HEMOPHILIA UTILIZATION GROUP STUDY V (HUGS V)
Niu X1;Poon JL1;Riske B2;Baker J3;Ullman M4;Gwadry-Sridhar F5;Lou M6, Nichol MB1
1University of Southern California, Los Angeles, CA, USA, 2University of Colorado Denver, Aurora, CO, USA, 3UCLA Division of Hematology/Oncology, Los Angeles, CA, USA, 4University of Texas Health Science Center at Houston, Houston, TX, USA, 5University of Western Ontario, London, ON, Canada, 6USC School of Pharmacy, Los Angeles, CA, USA
PIH45 - AGE-BASED OUTPATIENT ANTIBIOTIC PRESCRIBING IN THE UNITED STATES FROM 2000 TO 2010
Lee GC1;Daniels K1;Lawson KA2;Attridge RT3;Lewis J1, Frei CR1
1The University of Texas at Austin and The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA, 2The University of Texas at Austin, Austin, TX, USA, 3University of the Incarnate Word, San Antonio, TX, USA

Best New Investigator Poster Research Presentations

PCN51 - THE ECONOMIC BURDEN OF CANCER SURVIVORSHIP AMONG ADULTS IN THE UNITED STATES
Guy Jr. GP1;Ekwueme DU1;Yabroff KR2;Dowling EC3;Li C1;Rodriguez J1;de Moor JS2, Virgo KS4
1Centers for Disease Control and Prevention, Atlanta, GA, USA, 2National Cancer Institute, Bethesda, MD, USA, 3Institute for Technology Assessment, Boston, MA, USA, 4Emory University, Atlanta, GA, USA
PIH10 - FACTORS ASSOCIATED WITH INITIATION OF TESTOSTERONE REPLACEMENT THERAPY IN AGING MALES
An J;Niu F, Cheetham CT
Kaiser Permanente, Downey, CA, USA
PHS113 - COST-EFFECTIVENESS OF A COMPUTERIZED PROVIDER ORDER ENTRY SYSTEM IN IMPROVING MEDICATION SAFETY: A CASE STUDY IN AMBULATORY CARE
Hepp Z1;Forrester SH1;Roth J2;Wirtz HS1, Devine EB1
1University of Washington, Seattle, WA, USA, 2Group Health Cooperative, Seattle, WA, USA

 

ISPOR would like to thank all the judges who have volunteered their time and efforts during the meeting to score podium and poster research presentations.

 

Return to ISPOR Awards Index Page